Belinsky SA - Search Results

1

Nested multigene MSP/DHPLC method for analyzing promoter hypermethylation status in clinical samples.

Divine KK, Liechty KC, Crume KC, Belinsky SA. Divine KK, et al. Among authors: belinsky sa. Biotechniques. 2006 Jan;40(1):40, 42, 44 passim. doi: 10.2144/000112095. Biotechniques. 2006. PMID: 16454038 Free article. No abstract available.

2

Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.

Divine KK, Pulling LC, Marron-Terada PG, Liechty KC, Kang T, Schwartz AG, Bocklage TJ, Coons TA, Gilliland FD, Belinsky SA. Divine KK, et al. Among authors: belinsky sa. Int J Cancer. 2005 Apr 10;114(3):400-5. doi: 10.1002/ijc.20761. Int J Cancer. 2005. PMID: 15578700

3

Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.

Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE. Belinsky SA, et al. Cancer Res. 2002 Apr 15;62(8):2370-7. Cancer Res. 2002. PMID: 11956099

4

Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.

Pulling LC, Divine KK, Klinge DM, Gilliland FD, Kang T, Schwartz AG, Bocklage TJ, Belinsky SA. Pulling LC, et al. Among authors: belinsky sa. Cancer Res. 2003 Aug 15;63(16):4842-8. Cancer Res. 2003. PMID: 12941804

5

Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma.

Belinsky SA, Klinge DM, Liechty KC, March TH, Kang T, Gilliland FD, Sotnic N, Adamova G, Rusinova G, Telnov V. Belinsky SA, et al. Carcinogenesis. 2004 Jun;25(6):1063-7. doi: 10.1093/carcin/bgh096. Epub 2004 Jan 23. Carcinogenesis. 2004. PMID: 14742312

6

Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.

Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, Haney J, Kennedy TC, Hirsch FR, Miller Y, Franklin WA, Herman JG, Baylin SB, Bunn PA, Byers T. Belinsky SA, et al. Cancer Res. 2006 Mar 15;66(6):3338-44. doi: 10.1158/0008-5472.CAN-05-3408. Cancer Res. 2006. PMID: 16540689

7

Radiation-induced lung adenocarcinoma is associated with increased frequency of genes inactivated by promoter hypermethylation.

Lyon CM, Klinge DM, Liechty KC, Gentry FD, March TH, Kang T, Gilliland FD, Adamova G, Rusinova G, Telnov V, Belinsky SA. Lyon CM, et al. Among authors: belinsky sa. Radiat Res. 2007 Oct;168(4):409-14. doi: 10.1667/RR0825.1. Radiat Res. 2007. PMID: 17903034

8

Predicting lung cancer by detecting aberrant promoter methylation in sputum.

Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA. Palmisano WA, et al. Among authors: belinsky sa. Cancer Res. 2000 Nov 1;60(21):5954-8. Cancer Res. 2000. PMID: 11085511

9

The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung.

Divine KK, Gilliland FD, Crowell RE, Stidley CA, Bocklage TJ, Cook DL, Belinsky SA. Divine KK, et al. Among authors: belinsky sa. Mutat Res. 2001 Jan 5;461(4):273-8. doi: 10.1016/s0921-8777(00)00059-8. Mutat Res. 2001. PMID: 11104903

10

Gene-promoter hypermethylation as a biomarker in lung cancer.

Belinsky SA. Belinsky SA. Nat Rev Cancer. 2004 Sep;4(9):707-17. doi: 10.1038/nrc1432. Nat Rev Cancer. 2004. PMID: 15343277 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters